Journal of the American Academy of Dermatology
Volume 42, Issue 6 , Pages 1026-1029, June 2000

Botulinum toxin type A therapy for palmar and digital hyperhidrosis☆☆

State University of New York, Health Science Center at Brooklyn. Brooklyn, New York

Abstract 

Objective: We evaluated the efficacy of subepidermal injections of botulinum toxin type A on recalcitrant palmar and digital hyperhidrosis. Methods: Twenty patients with recalcitrant palmar and digital hyperhidrosis were treated with subepidermal injections of botulinum toxin. Nineteen patients completed the 12-month study. Injections were performed in 3 stages. The total dose of toxin for each hand, which included the palm, thenar eminence, and digits, was 165 units. Patients were followed up on a monthly basis. Results: Botulinum toxin significantly reduced sweat production in the treated areas. Anhidrosis lasted 9 months in 3 patients, 8 months in 3 patients, 7 months in 8 patients, 6 months in 3 patients, 5 months in 1 patient, and 4 months in 1 patient. Reduced sweating of the palm and digits continued in all patients for the 12-month evaluation period, with the greatest reduction of sweating in the nondominant hand. Mild weakness of the thumb occurred in 4 patients at a mean duration of 3 weeks, with the greatest duration being 6 weeks. Conclusion: Botulinum toxin provides a safe and efficacious alternative in the treatment of recalcitrant palmar and digital hyperhidrosis. (J Am Acad Dermatol 2000;42:1026–9.)

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by a grant from Allergan, Inc.

☆☆ Reprint requests: Barry A. Solomon, MD, JD, 222 Middle Country Rd, Suite 228, Smithtown, NY 11787.

 J Am Acad Dermatol 2000;42:1026–9

PII: S0190-9622(00)90298-6

doi:10.1016/S0190-9622(00)90298-6

Journal of the American Academy of Dermatology
Volume 42, Issue 6 , Pages 1026-1029, June 2000